PRLD Prelude Therapeutics Incorporated - Common Stock
PRLD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
PRLD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
PRLD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 3 33,3%
- Compra 5 55,6%
- Mantener 1 11,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
3 analistas · 2026-08-13Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.13 | $-0.25 | 0.12% |
| 31 de diciembre de 2025 | $-0.20 | $-0.03 | -0.17% |
| 30 de septiembre de 2025 | $-0.26 | $-0.37 | 0.11% |
| 30 de junio de 2025 | $-0.41 | $-0.45 | 0.04% |
| 31 de marzo de 2025 | $-0.42 | $-0.48 | 0.06% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $12M | $7M | |
| R&D Expense | $94M | $118M | |
| SG&A Expense | $22M | $29M | |
| Operating Expenses | $117M | $147M | |
| Operating Income | $-105M | $-140M | |
| Other Non-op | $5M | $13M | |
| Income Tax | $0 | $0 | |
| Net Income | $-99M | $-127M | |
| EPS (Basic) | $-1.29 | $-1.68 | |
| EPS (Diluted) | $-1.29 | $-1.68 | |
| Shares (Basic) | 76,956,194 | 75,805,840 | |
| Shares (Diluted) | 76,956,194 | 75,805,840 | |
| EBITDA | $-103M | $-138M |
Balance general 18
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $35M | $12M | |
| Short-term Investments | $68M | $121M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $106M | $136M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $12M | $12M | |
| Accum. Depreciation | $7M | $5M | |
| Total Assets | $141M | $176M | |
| Accounts Payable | $4M | $8M | |
| Accrued Liabilities | $13M | $15M | |
| Current Liabilities | $53M | $26M | |
| Capital Leases | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | |
| Total Liabilities | $73M | $44M | |
| Retained Earnings | $-683M | $-584M | |
| AOCI | $8.0K | $35.0K | |
| Stockholders' Equity | $69M | $131M | |
| Liabilities + Equity | $141M | $176M |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $2M | |
| Stock-based Comp | $12M | $21M | |
| Restructuring | $1M | · | |
| Other Non-cash | $30M | $1M | |
| Operating Cash Flow | $-56M | $-103M | |
| CapEx | $67.0K | $764.0K | |
| Investing Cash Flow | $53M | $90M | |
| Financing Cash Flow | $25M | $-120.0K | |
| Net Change in Cash | $22M | $-13M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-56M | $-104M |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -861.3% | -1995.9% | |
| Net Margin | -819.6% | -1816.8% | |
| EBITDA Margin | -847.2% | -1970.6% | |
| ROA | -62.8% | -56.1% | |
| ROE | -137.7% | -88.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.0 | 5.3 | |
| Quick Ratio | 1.9 | 5.2 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 73.4% | · |
Valoración (TTM) 4
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $12M | $7M | |
| Net Income TTM | $-99M | $-127M | |
| P/E | -2.2 | -0.8 | |
| Earnings Yield | -44.5% | -131.8% |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $5M | $6M | $6M | $0 | $0 | $4M | $3M | |
| R&D Expense | $16M | $14M | $18M | $22M | $26M | $29M | $32M | $29M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $8M | |
| Operating Expenses | $21M | $19M | $23M | $27M | $32M | $35M | $38M | $37M | |
| Operating Income | $-15M | $-14M | $-17M | $-20M | $-32M | $-35M | $-34M | $-34M | |
| Other Non-op | $2M | $4M | $891.0K | $693.0K | $963.0K | $3M | $5M | $2M | |
| Net Income | $-14M | $-10M | $-16M | $-20M | $-31M | $-32M | $-29M | $-32M | |
| EPS (Basic) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| EPS (Diluted) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| Shares (Basic) | 98,388,593 | 82,519,981 | -151,156,365 | 76,132,337 | 75,993,941 | 75,986,281 | -151,548,215 | 75,855,949 | |
| Shares (Diluted) | 98,388,593 | 82,519,981 | -151,156,365 | 76,132,337 | 75,993,941 | 75,986,281 | -151,548,215 | 75,855,949 | |
| EBITDA | $-15M | $-14M | · | $-20M | $-32M | $-34M | · | $-34M |
Balance general 18
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $22M | $35M | $48M | $26M | $40M | $12M | $11M | |
| Short-term Investments | $125M | $60M | $68M | $7M | $47M | $59M | $121M | $142M | |
| Prepaid Expense | $3M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | |
| Current Assets | $155M | $85M | $106M | $58M | $77M | $102M | $136M | $156M | |
| PP&E (Net) | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | · | · | $12M | · | · | · | $12M | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | |
| Total Assets | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M | |
| Accounts Payable | $2M | $2M | $4M | $3M | $5M | $6M | $8M | $6M | |
| Accrued Liabilities | $8M | $6M | $13M | $13M | $13M | $11M | $15M | $14M | |
| Current Liabilities | $38M | $42M | $53M | $18M | $21M | $20M | $26M | $22M | |
| Capital Leases | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Liabilities | $56M | $59M | $73M | $36M | $39M | $38M | $44M | $41M | |
| Retained Earnings | $-707M | $-693M | $-683M | $-667M | $-647M | $-616M | $-584M | $-555M | |
| AOCI | $-227.0K | $-41.0K | $8.0K | $2.0K | $-1.0K | $12.0K | $35.0K | $167.0K | |
| Stockholders' Equity | $134M | $60M | $69M | $59M | $76M | $103M | $131M | $156M | |
| Liabilities + Equity | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $353.0K | $391.0K | $418.0K | $425.0K | $433.0K | $435.0K | $489.0K | $405.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $6M | |
| Restructuring | $0 | $0 | $851.0K | $0 | · | · | · | · | |
| Other Non-cash | · | $-14M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-16M | $-22M | $23M | $-19M | $-26M | $-34M | $-21M | $-27M | |
| CapEx | $0 | $0 | $0 | $0 | $20.0K | $47.0K | $53.0K | $63.0K | |
| Investing Cash Flow | $-66M | $8M | $-60M | $40M | $12M | $62M | $22M | $11M | |
| Financing Cash Flow | $86M | $-314.0K | $25M | $-5.0K | $37.0K | $-160.0K | $-34.0K | $-131.0K | |
| Net Change in Cash | $5M | $-14M | $-12M | $21M | $-15M | $28M | $1M | $-17M | |
| Free Cash Flow | · | $-22M | · | · | · | $-34M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -270.9% | -309.5% | · | -314.1% | · | · | · | -1145.9% | |
| Net Margin | -244.1% | -226.8% | · | -303.5% | · | · | · | -1075.7% | |
| EBITDA Margin | -270.9% | -301.0% | · | -314.1% | · | · | · | -1145.9% | |
| ROA | -9.2% | -8.0% | · | -13.5% | -18.4% | -16.5% | · | -14.2% | |
| ROE | -13.3% | -12.7% | · | -18.4% | -24.2% | -20.4% | · | -16.4% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 2.0 | · | 3.2 | 3.7 | 5.2 | · | 7.0 | |
| Quick Ratio | 4.0 | 2.0 | · | 3.0 | 3.5 | 5.0 | · | 6.9 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 |
Valoración (TTM) 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | · | · | · | · | · | · | · | |
| Net Income TTM | $-75M | $-93M | · | $-115M | $-130M | $-131M | · | $-129M | |
| P/E | -5.7 | -2.8 | · | -0.9 | -0.5 | -0.4 | · | -1.2 | |
| Earnings Yield | -17.6% | -35.7% | · | -105.6% | -212.6% | -225.3% | · | -85.0% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $12M | $7M | — | — | — |
| Margen Operativo % | -861.3% | -1995.9% | — | — | — |
| Beneficio neto | $-99M | $-127M | $-122M | $-115M | $-112M |
| EPS Diluido | $-1.29 | $-1.68 | $-2.02 | $-2.44 | $-2.43 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.0 | 5.3 | 10.8 | 9.4 | 15.4 |
| Ratio Rápido | 1.9 | 5.2 | 10.7 | 9.3 | 15.2 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-56M | $-104M | $-111M | $-87M | $-86M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 86 declarantes · $247.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 43 (+32 vs trimestre anterior) | 11 (+7 vs trimestre anterior) | 21 (+2 vs trimestre anterior) | 9 (-1 vs trimestre anterior) | +18.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $73 151 963 | 13 724 571 | 29,56% | Acciones |
| BAKER BROS. ADVISORS LP | $53 959 982 | 10 123 824 | 21,80% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $34 516 451 | 6 475 882 | 13,95% | Acciones |
| Soleus Capital Management, L.P. | $18 006 755 | 3 378 378 | 7,28% | Acciones |
| Kynam Capital Management, LP | $12 872 414 | 2 415 087 | 5,20% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 710 342 | 2 009 445 | 4,33% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $5 435 705 | 1 019 832 | 2,20% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $5 294 657 | 993 369 | 2,14% | Acciones |
| ADAR1 Capital Management, LLC | $4 801 797 | 900 900 | 1,94% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $4 503 813 | 844 993 | 1,82% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4 083 286 | 766 095 | 1,65% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 751 819 | 703 768 | 1,52% | Acciones |
| STATE STREET CORP | $2 285 435 | 428 787 | 0,92% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 518 442 | 284 886 | 0,61% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 498 796 | 281 200 | 0,61% | Acciones |
| MORGAN STANLEY | $1 482 881 | 278 214 | 0,60% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 033 594 | 193 920 | 0,42% | Acciones |
| TWO SIGMA ADVISERS, LP | $688 170 | 237 300 | 0,28% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $664 571 | 124 685 | 0,27% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $591 630 | 111 000 | 0,24% | Opción de compra |
| VANGUARD GROUP INC | $456 402 | 157 380 | 0,18% | Acciones |
| Hillsdale Investment Management Inc. | $433 862 | 81 400 | 0,18% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $360 425 | 67 622 | 0,15% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $343 785 | 64 500 | 0,14% | Acciones |
| JANE STREET GROUP, LLC | $341 653 | 64 100 | 0,14% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $339 521 | 63 700 | 0,14% | Opción de venta |
| Squarepoint Ops LLC | $317 348 | 59 540 | 0,13% | Acciones |
| BlackRock, Inc. | $271 505 | 50 939 | 0,11% | Acciones |
| GOLDMAN SACHS GROUP INC | $265 199 | 49 756 | 0,11% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $253 569 | 47 574 | 0,10% | Acciones |
| Mariner, LLC | $241 241 | 45 261 | 0,10% | Acciones |
| Nuveen, LLC | $197 333 | 37 023 | 0,08% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $176 594 | 33 132 | 0,07% | Acciones |
| Cerity Partners LLC | $175 224 | 32 875 | 0,07% | Acciones |
| State of Wyoming | $175 154 | 32 862 | 0,07% | Acciones |
| CITADEL ADVISORS LLC | $166 829 | 31 300 | 0,07% | Opción de venta |
| Graham Capital Management, L.P. | $158 674 | 29 770 | 0,06% | Acciones |
| WELLS FARGO & COMPANY/MN | $134 982 | 25 325 | 0,05% | Acciones |
| BANK OF AMERICA CORP /DE/ | $127 254 | 23 875 | 0,05% | Acciones |
| RHUMBLINE ADVISERS | $117 649 | 22 074 | 0,05% | Acciones |
| JANE STREET GROUP, LLC | $107 133 | 20 100 | 0,04% | Opción de venta |
| Bank of New York Mellon Corp | $102 618 | 19 253 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $86 399 | 16 210 | 0,03% | Acciones |
| CITADEL ADVISORS LLC | $85 813 | 16 100 | 0,03% | Opción de compra |
| MARSHALL WACE, LLP | $83 845 | 15 731 | 0,03% | Acciones |
| ExodusPoint Capital Management, LP | $82 482 | 15 475 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $75 686 | 14 200 | 0,03% | Acciones |
| HSBC HOLDINGS PLC | $74 403 | 13 652 | 0,03% | Acciones |
| MANGROVE PARTNERS IM, LLC | $71 166 | 13 352 | 0,03% | Acciones |
| Qube Research & Technologies Ltd | $69 876 | 13 110 | 0,03% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68 139 | 12 784 | 0,03% | Acciones |
| BARCLAYS PLC | $66 811 | 12 535 | 0,03% | Acciones |
| CITIGROUP INC | $60 927 | 11 431 | 0,02% | Acciones |
| Invesco Ltd. | $59 008 | 11 071 | 0,02% | Acciones |
| Spark Investment Management LLC | $56 498 | 10 600 | 0,02% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $55 922 | 10 492 | 0,02% | Acciones |
| CITADEL ADVISORS LLC | $54 531 | 10 231 | 0,02% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $36 013 | 10 530 | 0,01% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $34 272 | 6 430 | 0,01% | Acciones |
| FMR LLC | $30 003 | 5 629 | 0,01% | Acciones |
| STRS OHIO | $29 315 | 5 500 | 0,01% | Acciones |
| NORTHERN TRUST CORP | $23 154 | 4 344 | 0,01% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $21 874 | 4 104 | 0,01% | Acciones |
| Nuveen Asset Management, LLC | $21 416 | 16 797 | 0,01% | Acciones |
| GROUP ONE TRADING LLC | $20 824 | 3 907 | 0,01% | Acciones |
| Legal & General Group Plc | $14 386 | 2 699 | 0,01% | Acciones |
| Ameritas Investment Partners, Inc. | $13 432 | 2 520 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $12 669 | 2 377 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $11 832 | 2 220 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $9 318 | 1 890 | 0,00% | Acciones |
| NISA INVESTMENT ADVISORS, LLC | $8 709 | 1 634 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $5 000 | 958 | 0,00% | Acciones |
| Quarry LP | $4 024 | 755 | 0,00% | Acciones |
| DEUTSCHE BANK AG\ | $3 950 | 741 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $3 253 | 611 359 | 0,00% | Acciones |
| PNC Financial Services Group, Inc. | $2 308 | 433 | 0,00% | Acciones |
| CWM, LLC | $1 960 | 573 | 0,00% | Acciones |
| Fortitude Family Office, LLC | $1 226 | 230 | 0,00% | Acciones |
| Sterling Capital Management LLC | $517 | 97 | 0,00% | Acciones |
| UBS Group AG | $123 | 23 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 22 758 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $117 | 22 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $96 | 18 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $68 | 12 672 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $27 | 5 | 0,00% | Acciones |
| Optiver Holding B.V. | $21 | 4 | 0,00% | Acciones |
Informantes de la empresa 15 insiders · 9 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Krishna Vaddi | CEO | 15 de febrero de 2022 A | 1 053 519 | 0 | 0 | $0 |
| Laurent Chardonnet | Chief Financial Officer | 21 de marzo de 2022 A | 14 500 | 0 | 0 | $0 |
| Brian Piper | Chief Financial Officer | 25 de agosto de 2021 M | 0 | 0 | 0 | $0 |
| Jane Huang | President, CMO | 4 de julio de 2023 M | 30 353 | 0 | 0 | $0 |
| Andrew Combs | EVP, Head of Chemistry | 1 de abril de 2022 M | 304 442 | 0 | 0 | $0 |
| Peggy Scherle | Chief Scientific Officer | 15 de febrero de 2022 A | 172 920 | 0 | 0 | $0 |
| Deborah Morosini | EVP, Chief of Clinical Affairs | 15 de febrero de 2022 A | 444 | 0 | 0 | $0 |
| David J Mauro | Chief Medical Officer | 5 de octubre de 2021 M | 0 | 0 | 0 | $0 |
| Christopher Pierce | EVP and Chief of Business Oper | 2 de septiembre de 2021 M | 3 750 | 0 | 0 | $0 |
| Victor Sandor | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Katina Dorton | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| David P Bonita | Consejero | 9 de junio de 2026 A | — | 2 | 0 | $12 499 998 |
| Martin Babler | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Consejero | 9 de junio de 2026 A | 500 098 | 0 | 0 | $0 |
| Mardi Dier | Consejero | 16 de junio de 2023 A | 10 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×4 presentaciones | 23 de abril de 2026 | 16,00% | Enmienda | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×6 presentaciones | 22 de abril de 2026 | 15,50% | Enmienda | Estructura de capital | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 13 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 19 657 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,03% | 93 079 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29 931 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 254 408 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 644 659 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 13 637 NS | 31 de mayo de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3 323 NS | 30 de abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7 414 NS | 30 de abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 348 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 458 355 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 513 825 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 160 484 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 505 SH | 8 de agosto de 2026 | Diario |